Companies › NUVB
NUVATION BIO INC (NUVB)
Institutional ownership, SEC filings and insider activity
Sector: Healthcare & Pharma · SEC CIK 0001811063 · EDGAR filings · Updated 2026-07-17
NUVATION BIO INC (NUVB) has reported institutional ownership of 63.3%, with 231 institutional managers holding positions valued at $943.6M per the latest 13F reporting period. SEC filings include an active non-reliance notice on previously issued financial statements (8-K Item 4.02), notice of delisting or failure to satisfy a continued listing rule (8-K Item 3.01).
Latest updates
- 2026-07-17 — Insider transaction reported (Form 4)
- 2026-07-06 — Current report (8-K) filed
- 2026-06-30 — Current report (8-K) filed
- 2026-06-29 — Prospectus supplement (424B5) filed
- 2026-06-29 — 305B2 filed
- 2026-06-26 — FWP filed
Institutional ownership overview
According to SEC 13F filings tracked by Sightfile, NUVATION BIO INC has 231 institutional holders and institutional ownership of 63.3%.
Insider activity
Insiders reported 34 transactions (11 buys, 11 sells) across 10 reporting insiders, with a net reported value of −$4.17M.
Data flags from SEC filings
Related companies
BIOLIFE SOLUTIONS INC COM NEW (BLFS) · FRESENIUS MEDICAL CARE AG (FMS) · PENNANT GROUP INC (PNTG) · IOVANCE BIOTHERAPEUTICS INC (IOVA) · FORTREA HLDGS INC (FTRE) · CULLINAN THERAPEUTICS INC (CGEM)
See full history, cross-references and alerts on SightfileData sources: SEC EDGAR (filings, 13F, FTD), aggregated by Sightfile. Page updated 2026-07-17.